Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-17-032090

Director sold 16,926 shares at an average $54.19 ($917,279)

  • Director acquired 16,926 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

FOOTE SUSAN BARTLETT · Director

Table I: Non-derivative

30 lines
Date Transaction Shares Price Value Owned after D/I
2017-11-10 Exercise or conversion : show line 1 in the form +6,573 $45.45 $298,743 27,313 D
2017-11-10 Sale : show line 2 in the form −290 $54.06 $15,677 27,023 D
2017-11-10 Sale : show line 3 in the form −200 $54.07 $10,814 26,823 D
2017-11-10 Sale : show line 4 in the form −400 $54.09 $21,636 26,423 D
2017-11-10 Sale : show line 5 in the form −510 $54.10 $27,591 25,913 D
2017-11-10 Sale : show line 6 in the form −1,200 $54.11 $64,932 24,713 D
2017-11-10 Sale : show line 7 in the form −600 $54.12 $32,472 24,113 D
2017-11-10 Sale : show line 8 in the form −600 $54.13 $32,478 23,513 D
Open-market sales · 16,926 sh · avg $54.19 · $917,279

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2017-11-10 Exercise or conversion : show line 31 in the form Non-qualified Stock Option (Right to Buy) −6,573 0 D
2017-11-10 Exercise or conversion : show line 32 in the form Non-qualified Stock Option (Right to Buy) −10,353 0 D
Loading xslF345X03/form4.xml…